Canopy Rivers Reports First Quarter Fiscal Year 2021 Financial Results

Formed Special Committee to oversee investment in PharmHouse Enhanced strategic exposure to cannabis 2.0 through investment in Dynaleo Achieved significant progress toward operating expense reduction targets Well-positioned for U.S. market development through key successes at TerrAscend – Canopy Rivers Inc. (the “Company” or “Canopy Rivers“) (TSX: RIV) (OTC: CNPOF) today released its unaudited condensed interim consolidated financialContinue reading “Canopy Rivers Reports First Quarter Fiscal Year 2021 Financial Results”

Liberty Health Sciences Reports Fiscal Year 2021 First Quarter Financial Results

*Note: All references to dollar values refer to Canadian dollars unless otherwise stated. – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of high-quality cannabis, announced its financial results for the first quarter ended May 31, 2020. Consolidated net sales for the quarter ended May 31, 2020 were $18,440,756, compared with $5,520,561 for the quarter ended May 31,Continue reading “Liberty Health Sciences Reports Fiscal Year 2021 First Quarter Financial Results”